Global Vaccines Administered Orally Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Vaccines Administered Orally market size was valued at US$ 1833.2 million in 2023. With growing demand in downstream market, the Vaccines Administered Orally is forecast to a readjusted size of US$ 2797.6 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Vaccines Administered Orally market. Vaccines Administered Orally are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccines Administered Orally. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccines Administered Orally market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.
Key Features:
The report on Vaccines Administered Orally market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccines Administered Orally market. It may include historical data, market segmentation by Type (e.g., Human, Animal), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccines Administered Orally market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccines Administered Orally market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccines Administered Orally industry. This include advancements in Vaccines Administered Orally technology, Vaccines Administered Orally new entrants, Vaccines Administered Orally new investment, and other innovations that are shaping the future of Vaccines Administered Orally.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccines Administered Orally market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccines Administered Orally product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccines Administered Orally market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccines Administered Orally market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccines Administered Orally market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccines Administered Orally industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccines Administered Orally market.
Market Segmentation:
Vaccines Administered Orally market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Vaccines Administered Orally market?
What factors are driving Vaccines Administered Orally market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines Administered Orally market opportunities vary by end market size?
How does Vaccines Administered Orally break out type, application?
According to our LPI (LP Information) latest study, the global Vaccines Administered Orally market size was valued at US$ 1833.2 million in 2023. With growing demand in downstream market, the Vaccines Administered Orally is forecast to a readjusted size of US$ 2797.6 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Vaccines Administered Orally market. Vaccines Administered Orally are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccines Administered Orally. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccines Administered Orally market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.
Key Features:
The report on Vaccines Administered Orally market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccines Administered Orally market. It may include historical data, market segmentation by Type (e.g., Human, Animal), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccines Administered Orally market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccines Administered Orally market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccines Administered Orally industry. This include advancements in Vaccines Administered Orally technology, Vaccines Administered Orally new entrants, Vaccines Administered Orally new investment, and other innovations that are shaping the future of Vaccines Administered Orally.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccines Administered Orally market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccines Administered Orally product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccines Administered Orally market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccines Administered Orally market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccines Administered Orally market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccines Administered Orally industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccines Administered Orally market.
Market Segmentation:
Vaccines Administered Orally market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Human
- Animal
- Public
- Private
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
What is the 10-year outlook for the global Vaccines Administered Orally market?
What factors are driving Vaccines Administered Orally market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines Administered Orally market opportunities vary by end market size?
How does Vaccines Administered Orally break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines Administered Orally Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Vaccines Administered Orally by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Vaccines Administered Orally by Country/Region, 2019, 2023 & 2030
2.2 Vaccines Administered Orally Segment by Type
2.2.1 Human
2.2.2 Animal
2.3 Vaccines Administered Orally Sales by Type
2.3.1 Global Vaccines Administered Orally Sales Market Share by Type (2019-2024)
2.3.2 Global Vaccines Administered Orally Revenue and Market Share by Type (2019-2024)
2.3.3 Global Vaccines Administered Orally Sale Price by Type (2019-2024)
2.4 Vaccines Administered Orally Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Vaccines Administered Orally Sales by Application
2.5.1 Global Vaccines Administered Orally Sale Market Share by Application (2019-2024)
2.5.2 Global Vaccines Administered Orally Revenue and Market Share by Application (2019-2024)
2.5.3 Global Vaccines Administered Orally Sale Price by Application (2019-2024)
3 GLOBAL VACCINES ADMINISTERED ORALLY BY COMPANY
3.1 Global Vaccines Administered Orally Breakdown Data by Company
3.1.1 Global Vaccines Administered Orally Annual Sales by Company (2019-2024)
3.1.2 Global Vaccines Administered Orally Sales Market Share by Company (2019-2024)
3.2 Global Vaccines Administered Orally Annual Revenue by Company (2019-2024)
3.2.1 Global Vaccines Administered Orally Revenue by Company (2019-2024)
3.2.2 Global Vaccines Administered Orally Revenue Market Share by Company (2019-2024)
3.3 Global Vaccines Administered Orally Sale Price by Company
3.4 Key Manufacturers Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Administered Orally Product Location Distribution
3.4.2 Players Vaccines Administered Orally Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINES ADMINISTERED ORALLY BY GEOGRAPHIC REGION
4.1 World Historic Vaccines Administered Orally Market Size by Geographic Region (2019-2024)
4.1.1 Global Vaccines Administered Orally Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Vaccines Administered Orally Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Vaccines Administered Orally Market Size by Country/Region (2019-2024)
4.2.1 Global Vaccines Administered Orally Annual Sales by Country/Region (2019-2024)
4.2.2 Global Vaccines Administered Orally Annual Revenue by Country/Region (2019-2024)
4.3 Americas Vaccines Administered Orally Sales Growth
4.4 APAC Vaccines Administered Orally Sales Growth
4.5 Europe Vaccines Administered Orally Sales Growth
4.6 Middle East & Africa Vaccines Administered Orally Sales Growth
5 AMERICAS
5.1 Americas Vaccines Administered Orally Sales by Country
5.1.1 Americas Vaccines Administered Orally Sales by Country (2019-2024)
5.1.2 Americas Vaccines Administered Orally Revenue by Country (2019-2024)
5.2 Americas Vaccines Administered Orally Sales by Type
5.3 Americas Vaccines Administered Orally Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Administered Orally Sales by Region
6.1.1 APAC Vaccines Administered Orally Sales by Region (2019-2024)
6.1.2 APAC Vaccines Administered Orally Revenue by Region (2019-2024)
6.2 APAC Vaccines Administered Orally Sales by Type
6.3 APAC Vaccines Administered Orally Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines Administered Orally by Country
7.1.1 Europe Vaccines Administered Orally Sales by Country (2019-2024)
7.1.2 Europe Vaccines Administered Orally Revenue by Country (2019-2024)
7.2 Europe Vaccines Administered Orally Sales by Type
7.3 Europe Vaccines Administered Orally Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines Administered Orally by Country
8.1.1 Middle East & Africa Vaccines Administered Orally Sales by Country (2019-2024)
8.1.2 Middle East & Africa Vaccines Administered Orally Revenue by Country (2019-2024)
8.2 Middle East & Africa Vaccines Administered Orally Sales by Type
8.3 Middle East & Africa Vaccines Administered Orally Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines Administered Orally
10.3 Manufacturing Process Analysis of Vaccines Administered Orally
10.4 Industry Chain Structure of Vaccines Administered Orally
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Administered Orally Distributors
11.3 Vaccines Administered Orally Customer
12 WORLD FORECAST REVIEW FOR VACCINES ADMINISTERED ORALLY BY GEOGRAPHIC REGION
12.1 Global Vaccines Administered Orally Market Size Forecast by Region
12.1.1 Global Vaccines Administered Orally Forecast by Region (2025-2030)
12.1.2 Global Vaccines Administered Orally Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines Administered Orally Forecast by Type
12.7 Global Vaccines Administered Orally Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Vaccines Administered Orally Product Portfolios and Specifications
13.1.3 Merck Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Vaccines Administered Orally Product Portfolios and Specifications
13.2.3 GSK Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Vaccines Administered Orally Product Portfolios and Specifications
13.3.3 Sanofi Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Vaccines Administered Orally Product Portfolios and Specifications
13.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Vaccines Administered Orally Product Portfolios and Specifications
13.5.3 Serum Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Vaccines Administered Orally Product Portfolios and Specifications
13.6.3 Valneva Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Vaccines Administered Orally Product Portfolios and Specifications
13.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Vaccines Administered Orally Product Portfolios and Specifications
13.8.3 Bibcol Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Vaccines Administered Orally Product Portfolios and Specifications
13.9.3 PaxVax Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Vaccines Administered Orally Product Portfolios and Specifications
13.10.3 Vabiotech Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Vaccines Administered Orally Product Portfolios and Specifications
13.11.3 Tiantan Biological Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Vaccines Administered Orally Product Portfolios and Specifications
13.12.3 EuBiologics Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Vaccines Administered Orally Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Vaccines Administered Orally Product Portfolios and Specifications
13.14.3 Bio-Med Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vaccines Administered Orally Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Human
Table 4. Major Players of Animal
Table 5. Global Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 6. Global Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Table 7. Global Vaccines Administered Orally Revenue by Type (2019-2024) & ($ million)
Table 8. Global Vaccines Administered Orally Revenue Market Share by Type (2019-2024)
Table 9. Global Vaccines Administered Orally Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 11. Global Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Table 12. Global Vaccines Administered Orally Revenue by Application (2019-2024)
Table 13. Global Vaccines Administered Orally Revenue Market Share by Application (2019-2024)
Table 14. Global Vaccines Administered Orally Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Vaccines Administered Orally Sales by Company (2019-2024) & (K Units)
Table 16. Global Vaccines Administered Orally Sales Market Share by Company (2019-2024)
Table 17. Global Vaccines Administered Orally Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Vaccines Administered Orally Revenue Market Share by Company (2019-2024)
Table 19. Global Vaccines Administered Orally Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area
Table 21. Players Vaccines Administered Orally Products Offered
Table 22. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaccines Administered Orally Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Vaccines Administered Orally Sales Market Share Geographic Region (2019-2024)
Table 27. Global Vaccines Administered Orally Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Vaccines Administered Orally Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Vaccines Administered Orally Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Vaccines Administered Orally Sales Market Share by Country/Region (2019-2024)
Table 31. Global Vaccines Administered Orally Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Vaccines Administered Orally Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 34. Americas Vaccines Administered Orally Sales Market Share by Country (2019-2024)
Table 35. Americas Vaccines Administered Orally Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Vaccines Administered Orally Revenue Market Share by Country (2019-2024)
Table 37. Americas Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 38. Americas Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 39. APAC Vaccines Administered Orally Sales by Region (2019-2024) & (K Units)
Table 40. APAC Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Table 41. APAC Vaccines Administered Orally Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
Table 43. APAC Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 44. APAC Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 45. Europe Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 46. Europe Vaccines Administered Orally Sales Market Share by Country (2019-2024)
Table 47. Europe Vaccines Administered Orally Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Vaccines Administered Orally Revenue Market Share by Country (2019-2024)
Table 49. Europe Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 50. Europe Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Vaccines Administered Orally Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vaccines Administered Orally
Table 58. Key Market Challenges & Risks of Vaccines Administered Orally
Table 59. Key Industry Trends of Vaccines Administered Orally
Table 60. Vaccines Administered Orally Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vaccines Administered Orally Distributors List
Table 63. Vaccines Administered Orally Customer List
Table 64. Global Vaccines Administered Orally Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Vaccines Administered Orally Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Vaccines Administered Orally Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Vaccines Administered Orally Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Vaccines Administered Orally Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Vaccines Administered Orally Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Vaccines Administered Orally Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Vaccines Administered Orally Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Vaccines Administered Orally Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Vaccines Administered Orally Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Vaccines Administered Orally Product Portfolios and Specifications
Table 80. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Vaccines Administered Orally Product Portfolios and Specifications
Table 85. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Vaccines Administered Orally Product Portfolios and Specifications
Table 90. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 94. Lanzhou Institute Vaccines Administered Orally Product Portfolios and Specifications
Table 95. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Lanzhou Institute Main Business
Table 97. Lanzhou Institute Latest Developments
Table 98. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute Vaccines Administered Orally Product Portfolios and Specifications
Table 100. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Serum Institute Main Business
Table 102. Serum Institute Latest Developments
Table 103. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 104. Valneva Vaccines Administered Orally Product Portfolios and Specifications
Table 105. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Valneva Main Business
Table 107. Valneva Latest Developments
Table 108. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai United Cell Vaccines Administered Orally Product Portfolios and Specifications
Table 110. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Shanghai United Cell Main Business
Table 112. Shanghai United Cell Latest Developments
Table 113. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 114. Bibcol Vaccines Administered Orally Product Portfolios and Specifications
Table 115. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Bibcol Main Business
Table 117. Bibcol Latest Developments
Table 118. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 119. PaxVax Vaccines Administered Orally Product Portfolios and Specifications
Table 120. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. PaxVax Main Business
Table 122. PaxVax Latest Developments
Table 123. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 124. Vabiotech Vaccines Administered Orally Product Portfolios and Specifications
Table 125. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Vabiotech Main Business
Table 127. Vabiotech Latest Developments
Table 128. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 129. Tiantan Biological Vaccines Administered Orally Product Portfolios and Specifications
Table 130. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Tiantan Biological Main Business
Table 132. Tiantan Biological Latest Developments
Table 133. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 134. EuBiologics Vaccines Administered Orally Product Portfolios and Specifications
Table 135. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. EuBiologics Main Business
Table 137. EuBiologics Latest Developments
Table 138. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 139. Panacea Biotec Ltd Vaccines Administered Orally Product Portfolios and Specifications
Table 140. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Panacea Biotec Ltd Main Business
Table 142. Panacea Biotec Ltd Latest Developments
Table 143. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 144. Bio-Med Vaccines Administered Orally Product Portfolios and Specifications
Table 145. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Bio-Med Main Business
Table 147. Bio-Med Latest Developments
Table 148. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 149. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Portfolios and Specifications
Table 150. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Halfkin Bio-Pharmaceuticals Main Business
Table 152. Halfkin Bio-Pharmaceuticals Latest Developments
Table 1. Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vaccines Administered Orally Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Human
Table 4. Major Players of Animal
Table 5. Global Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 6. Global Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Table 7. Global Vaccines Administered Orally Revenue by Type (2019-2024) & ($ million)
Table 8. Global Vaccines Administered Orally Revenue Market Share by Type (2019-2024)
Table 9. Global Vaccines Administered Orally Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 11. Global Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Table 12. Global Vaccines Administered Orally Revenue by Application (2019-2024)
Table 13. Global Vaccines Administered Orally Revenue Market Share by Application (2019-2024)
Table 14. Global Vaccines Administered Orally Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Vaccines Administered Orally Sales by Company (2019-2024) & (K Units)
Table 16. Global Vaccines Administered Orally Sales Market Share by Company (2019-2024)
Table 17. Global Vaccines Administered Orally Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Vaccines Administered Orally Revenue Market Share by Company (2019-2024)
Table 19. Global Vaccines Administered Orally Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area
Table 21. Players Vaccines Administered Orally Products Offered
Table 22. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaccines Administered Orally Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Vaccines Administered Orally Sales Market Share Geographic Region (2019-2024)
Table 27. Global Vaccines Administered Orally Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Vaccines Administered Orally Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Vaccines Administered Orally Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Vaccines Administered Orally Sales Market Share by Country/Region (2019-2024)
Table 31. Global Vaccines Administered Orally Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Vaccines Administered Orally Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 34. Americas Vaccines Administered Orally Sales Market Share by Country (2019-2024)
Table 35. Americas Vaccines Administered Orally Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Vaccines Administered Orally Revenue Market Share by Country (2019-2024)
Table 37. Americas Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 38. Americas Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 39. APAC Vaccines Administered Orally Sales by Region (2019-2024) & (K Units)
Table 40. APAC Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Table 41. APAC Vaccines Administered Orally Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
Table 43. APAC Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 44. APAC Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 45. Europe Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 46. Europe Vaccines Administered Orally Sales Market Share by Country (2019-2024)
Table 47. Europe Vaccines Administered Orally Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Vaccines Administered Orally Revenue Market Share by Country (2019-2024)
Table 49. Europe Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 50. Europe Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Vaccines Administered Orally Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vaccines Administered Orally
Table 58. Key Market Challenges & Risks of Vaccines Administered Orally
Table 59. Key Industry Trends of Vaccines Administered Orally
Table 60. Vaccines Administered Orally Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vaccines Administered Orally Distributors List
Table 63. Vaccines Administered Orally Customer List
Table 64. Global Vaccines Administered Orally Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Vaccines Administered Orally Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Vaccines Administered Orally Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Vaccines Administered Orally Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Vaccines Administered Orally Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Vaccines Administered Orally Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Vaccines Administered Orally Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Vaccines Administered Orally Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Vaccines Administered Orally Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Vaccines Administered Orally Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Vaccines Administered Orally Product Portfolios and Specifications
Table 80. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Vaccines Administered Orally Product Portfolios and Specifications
Table 85. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Vaccines Administered Orally Product Portfolios and Specifications
Table 90. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 94. Lanzhou Institute Vaccines Administered Orally Product Portfolios and Specifications
Table 95. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Lanzhou Institute Main Business
Table 97. Lanzhou Institute Latest Developments
Table 98. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute Vaccines Administered Orally Product Portfolios and Specifications
Table 100. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Serum Institute Main Business
Table 102. Serum Institute Latest Developments
Table 103. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 104. Valneva Vaccines Administered Orally Product Portfolios and Specifications
Table 105. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Valneva Main Business
Table 107. Valneva Latest Developments
Table 108. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai United Cell Vaccines Administered Orally Product Portfolios and Specifications
Table 110. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Shanghai United Cell Main Business
Table 112. Shanghai United Cell Latest Developments
Table 113. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 114. Bibcol Vaccines Administered Orally Product Portfolios and Specifications
Table 115. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Bibcol Main Business
Table 117. Bibcol Latest Developments
Table 118. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 119. PaxVax Vaccines Administered Orally Product Portfolios and Specifications
Table 120. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. PaxVax Main Business
Table 122. PaxVax Latest Developments
Table 123. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 124. Vabiotech Vaccines Administered Orally Product Portfolios and Specifications
Table 125. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Vabiotech Main Business
Table 127. Vabiotech Latest Developments
Table 128. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 129. Tiantan Biological Vaccines Administered Orally Product Portfolios and Specifications
Table 130. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Tiantan Biological Main Business
Table 132. Tiantan Biological Latest Developments
Table 133. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 134. EuBiologics Vaccines Administered Orally Product Portfolios and Specifications
Table 135. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. EuBiologics Main Business
Table 137. EuBiologics Latest Developments
Table 138. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 139. Panacea Biotec Ltd Vaccines Administered Orally Product Portfolios and Specifications
Table 140. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Panacea Biotec Ltd Main Business
Table 142. Panacea Biotec Ltd Latest Developments
Table 143. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 144. Bio-Med Vaccines Administered Orally Product Portfolios and Specifications
Table 145. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Bio-Med Main Business
Table 147. Bio-Med Latest Developments
Table 148. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 149. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Portfolios and Specifications
Table 150. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Halfkin Bio-Pharmaceuticals Main Business
Table 152. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccines Administered Orally
Figure 2. Vaccines Administered Orally Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vaccines Administered Orally Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Human
Figure 10. Product Picture of Animal
Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2023
Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2019-2024)
Figure 13. Vaccines Administered Orally Consumed in Public
Figure 14. Global Vaccines Administered Orally Market: Public (2019-2024) & (K Units)
Figure 15. Vaccines Administered Orally Consumed in Private
Figure 16. Global Vaccines Administered Orally Market: Private (2019-2024) & (K Units)
Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2023)
Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2023
Figure 19. Vaccines Administered Orally Sales Market by Company in 2023 (K Units)
Figure 20. Global Vaccines Administered Orally Sales Market Share by Company in 2023
Figure 21. Vaccines Administered Orally Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Vaccines Administered Orally Revenue Market Share by Company in 2023
Figure 23. Global Vaccines Administered Orally Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Vaccines Administered Orally Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 26. Americas Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 27. APAC Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 28. APAC Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 29. Europe Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 30. Europe Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 33. Americas Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 34. Americas Vaccines Administered Orally Revenue Market Share by Country in 2023
Figure 35. Americas Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 36. Americas Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 37. United States Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Vaccines Administered Orally Sales Market Share by Region in 2023
Figure 42. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2023
Figure 43. APAC Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 44. APAC Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 45. China Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 53. Europe Vaccines Administered Orally Revenue Market Share by Country in 2023
Figure 54. Europe Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 55. Europe Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 56. Germany Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 65. Egypt Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vaccines Administered Orally in 2023
Figure 71. Manufacturing Process Analysis of Vaccines Administered Orally
Figure 72. Industry Chain Structure of Vaccines Administered Orally
Figure 73. Channels of Distribution
Figure 74. Global Vaccines Administered Orally Sales Market Forecast by Region (2025-2030)
Figure 75. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Vaccines Administered Orally
Figure 2. Vaccines Administered Orally Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vaccines Administered Orally Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Human
Figure 10. Product Picture of Animal
Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2023
Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2019-2024)
Figure 13. Vaccines Administered Orally Consumed in Public
Figure 14. Global Vaccines Administered Orally Market: Public (2019-2024) & (K Units)
Figure 15. Vaccines Administered Orally Consumed in Private
Figure 16. Global Vaccines Administered Orally Market: Private (2019-2024) & (K Units)
Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2023)
Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2023
Figure 19. Vaccines Administered Orally Sales Market by Company in 2023 (K Units)
Figure 20. Global Vaccines Administered Orally Sales Market Share by Company in 2023
Figure 21. Vaccines Administered Orally Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Vaccines Administered Orally Revenue Market Share by Company in 2023
Figure 23. Global Vaccines Administered Orally Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Vaccines Administered Orally Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 26. Americas Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 27. APAC Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 28. APAC Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 29. Europe Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 30. Europe Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Vaccines Administered Orally Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Vaccines Administered Orally Revenue 2019-2024 ($ Millions)
Figure 33. Americas Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 34. Americas Vaccines Administered Orally Revenue Market Share by Country in 2023
Figure 35. Americas Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 36. Americas Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 37. United States Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Vaccines Administered Orally Sales Market Share by Region in 2023
Figure 42. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2023
Figure 43. APAC Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 44. APAC Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 45. China Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 53. Europe Vaccines Administered Orally Revenue Market Share by Country in 2023
Figure 54. Europe Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 55. Europe Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 56. Germany Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 65. Egypt Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Vaccines Administered Orally Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vaccines Administered Orally in 2023
Figure 71. Manufacturing Process Analysis of Vaccines Administered Orally
Figure 72. Industry Chain Structure of Vaccines Administered Orally
Figure 73. Channels of Distribution
Figure 74. Global Vaccines Administered Orally Sales Market Forecast by Region (2025-2030)
Figure 75. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Cryotherapy Units Market Growth 2025-2031
US$ 3,660.00
March 2025
144 pages
Global Injectable Drugs For Diabetes Market Growth 2023-2029
US$ 3,660.00
March 2023
97 pages
Global Glycoprotein Market Growth 2025-2031
US$ 3,660.00
March 2025
90 pages
Global 3D Printing for Dental Market Growth 2024-2030
US$ 3,660.00
October 2024
117 pages
